References
- Ashton H. The diagnosis and management of benzodiazepine dependence. Curr Opin Psychiatry. 2005;18(3):249–255.
- Guina J, Merrill B. Benzodiazepines I: upping the care on downers: the evidence of risks, benefits and alternatives. J Clin Med. 2018 Jan 30;7(2). pii: E17. doi: 10.3390/jcm7020017.
- Dowell D, Haegerich TM, Chou R. CDC guideline for prescribing opioids for chronic pain–United States, 2016. Jama. 2016;315(15):1624–1645.
- National Institute on Drug Abuse. Benzodiazepines and Opioids. National Institute on Drug Abuse; 2019 [cited 2019 Dec 8]. Available from: https://www.drugabuse.gov/drugs-abuse/opioids/benzodiazepines-opioids
- Dasgupta N, Funk MJ, Proescholdbell S, et al. Cohort study of the impact of high-dose opioid analgesics on overdose mortality. Pain Med. 2016;17(1):85–98.
- Griffin CE 3rd, Kaye AM, Bueno FR, et al. Benzodiazepine pharmacology and central nervous system-mediated effects. Ochsner J. 2013;13(2):214–223.
- Bandelow B, Zohar J, Hollander E, et al. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of anxiety, obsessive-compulsive and post-traumatic stress disorders - first revision. World J Biol Psychiatry. 2008;9(4):248–312.
- Bandelow B, Michaelis S, Wedekind D. Treatment of anxiety disorders. Dialogues Clin Neurosci. 2017;19(2):93–107.
- Riemann D, Baglioni C, Bassetti C, et al. European guideline for the diagnosis and treatment of insomnia. J Sleep Res. 2017;26(6):675–700.
- Sateia MJ, Buysse DJ, Krystal AD, et al. Clinical practice guideline for the pharmacologic treatment of chronic insomnia in adults: an american academy of sleep medicine clinical practice guideline. J Clin Sleep Med. 2017;13(2):307–349.
- Wilt TJ, MacDonald R, Brasure M, et al. Pharmacologic treatment of insomnia disorder: an evidence report for a clinical practice guideline by the American College of Physicians. Ann Intern Med. 2016;165(2):103–112.
- Guina J, Rossetter SR, De RB, et al. Benzodiazepines for PTSD: a systematic review and meta-analysis. J Psychiatr Pract. 2015;21(4):281–303.
- Soric MM, Paxos C, Dugan SE, et al. Prevalence and predictors of benzodiazepine monotherapy in patients with depression: a national cross-sectional study. J Clin Psychiatry. 2019 May 21;80(4). pii: 18m12588. doi: 10.4088/JCP.18m12588.
- Wlodarczyk A. Benzodiazepine use in schizophrenia. Schizophr Res. 2018;195:576.
- Starcevic V, Berle D, Do Rosario MC, et al. Use of benzodiazepines in obsessive-compulsive disorder. Int Clin Psychopharmacol. 2016;31(1):27–33.
- Guina J, Nahhas RW, Welton RS. No role for benzodiazepines in posttraumatic stress disorder until supported by evidence. Australas Psychiatry. 2017;25(4):415–416.
- Kaufmann CN, Spira AP, Depp CA, et al. Long-term use of benzodiazepines and nonbenzodiazepine hypnotics, 1999–2014. Psychiatr Serv. 2018;69(2):235–238.
- Cunningham JL, Craner JR, Evans MM, et al. Benzodiazepine use in patients with chronic pain in an interdisciplinary pain rehabilitation program. J Pain Res. 2017;10:311–317.
- Allison C, Pratt JA. Neuroadaptive processes in GABAergic and glutamatergic systems in benzodiazepine dependence. Pharmacol Ther. 2003;98(2):171–195.
- Lader M. Benzodiazepine harm: how can it be reduced? Br J Clin Pharmacol. 2014;77(2):295–301.
- King SA, Strain JJ. Benzodiazepine use by chronic pain patients. Clin J Pain. 1990;6(2):143–147.
- Nielsen S, Lintzeris N, Bruno R, et al. Benzodiazepine use among chronic pain patients prescribed opioids: associations with pain, physical and mental health, and health service utilization. Pain Med. 2015;16(2):356–366.
- Zis P, Daskalaki A, Bountouni I, et al. Depression and chronic pain in the elderly: links and management challenges. Clin Interv Aging. 2017;12:709–720.
- Mills SEE, Nicolson KP, Smith BH. Chronic pain: a review of its epidemiology and associated factors in population-based studies. Br J Anaesth. 2019;123(2):e273–e283.
- Knappich M, Horz-Sagstetter S, Schwerthoffer D, et al. Pharmacotherapy in the treatment of patients with borderline personality disorder: results of a survey among psychiatrists in private practices. Int Clin Psychopharmacol. 2014;29(4):224–228.